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Adenylyl Cyclase 6 Improves Calcium Uptake
and Left Ventricular Function in Aged Hearts
Tong Tang, PHD,*† H. Kirk Hammond, MD,*† Amy Firth, PHD,† Yuan Yang, MD,†
Mei Hua Gao, PHD,*† Jason X.-J. Yuan, MD, PHD,† N. Chin Lai, PHD*†
San Diego and La Jolla, California
Objectives This study tested the hypothesis that activation of adenylyl cyclase 6 (AC6) expression in cardiac myocytes im-
proves calcium uptake and left ventricular (LV) function in aging mice.
Background Aging hearts exhibit impaired -adrenergic receptor signaling and LV dysfunction.
Methods Twenty-month-old mice with cardiac-directed and regulated AC6 expression were randomized into 2 groups, and
AC6 expression was activated in 1 group (AC6-On) but not the other (AC6-Off). One month later, LV function and
sarcoplasmic reticulum calcium uptake were assessed.
Results AC6 expression was associated with increased LV contractility, as reflected by ejection fraction
(p  0.02), rate of pressure development (p  0.002), and slope of the LV end-systolic pressure-volume relation-
ship (p  0.04). No changes in LV weight to tibial length ratio, LV fibrosis, and expression of fetal genes (atrial
natriuretic factor, -skeletal muscle actin, and -myosin heavy chain) and collagens were observed between
AC6-On and AC6-Off groups. However, LV samples from AC6-On mice showed increases in: isoproterenol-
stimulated cAMP production (p  0.04), cAMP-dependent protein kinase activity (p  0.0004), phosphorylation
of phospholamban (at Ser16 site; p  0.04) and cardiac troponin I (at Ser23/24 sites; p  0.01), velocity of
sarcoplasmic reticulum calcium uptake (p  0.0001), and sarcoplasmic reticulum calcium-ATPase2a (SERCA2a)
affinity for calcium (p  0.0001). Finally, we found that AC6 expression increased sarcoplasmic reticulum cal-
cium storage in cardiac myocytes isolated from 23-month-old rats. In contrast, AC6 expression in 7-month-old
mice did not change LV function and calcium uptake.
Conclusions These results indicate that activation of cardiac AC6 expression improves impaired function of aged hearts
through improved calcium uptake. (J Am Coll Cardiol 2011;57:1846–55) © 2011 by the American College of
Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.11.052s
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ACardiac senescence is associated with reduced left ventric-
ular (LV) function (1–4) and impaired cardiac -adrenergic
receptor (AR) responsiveness (5). In humans, LV diastolic
nd systolic functions in response to AR stimulation
rogressively decrease after the age of 20 years. At age 80
ears, LV contractile reserve is less than one-half of what it
as at age 20 years (6). In addition, congestive heart failure
CHF) is a common disease of the elderly (7–9), and older
atients with CHF have a particularly poor prognosis (8).
Adenylyl cyclase (AC) is the effector molecule for AR
ignaling (10), playing a pivotal role in contractile respon-
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2010, accepted November 9, 2010.iveness, cardiac relaxation, and LV diastolic function (11).
C catalyzes ATP to generate cAMP, a second messenger
hat is required for many intracellular events (12). Reduced
AR responsiveness in aging hearts occurs in the presence
of increased plasma catecholamine levels (13), underscoring
the abnormality in AC signaling (5,14). Indeed, impaired
LV cAMP production is associated with decreased cardiac
AC content in hearts from animals of advanced age (15,16).
However, the precise mechanism by which AC regulates
cardiac function in aging hearts is not known and is the
focus of the current investigation.
Cardiac-directed expression of AC type 6 (AC6) in-
creases LV function in CHF (17,18), in which impaired
AR-AC signaling and impaired calcium uptake are
rominent (19). Increased cardiac cAMP production and
mproved sarcoplasmic reticulum (SR) calcium uptake are
f mechanistic importance for the beneficial effect of
C6 on failing hearts (18,20). In this study, we used aransgenic line with cardiac-directed tetracycline-regulated
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May 3, 2011:1846–55 AC6 Function in Aged HeartsAC6 expression (21,22) to test the hypothesis that activa-
tion of cardiac AC6 expression improves LV function by
increasing cardiac cAMP production and correcting calcium
uptake impairment in hearts from older mice.
Methods
Animals. The Animal Use and Care Committee of the VA
San Diego Healthcare System, in accordance with National
Institutes of Health and Association for Assessment and
Accreditation of Laboratory Animal Care guidelines, ap-
proved this study. Twenty-month-old transgenic mice with
cardiac myocyte–specific tetracycline-regulated (tet-off)
AC6 expression (22) were used for echocardiography, in
vivo physiology, and biochemistry studies. Adenylyl cyclase
6 transgene expression is completely suppressed until tetra-
cycline is removed from the water supply, and chronic
tetracycline treatment did not affect cardiac function. Mice
were randomized into 2 groups. AC6 expression was acti-
vated (by removing tetracycline suppression) in one group
(AC6-On) and was continuously suppressed by tetracycline
in the other group (AC6-Off). These mice were studied 1
month after activation (or continued inactivation) of AC6
transgene expression. For comparison, echocardiography, in
vivo physiology, and biochemistry studies were also per-
formed on 7-month-old tetracycline-regulated AC6 mice.
For calcium transients study, cardiac myocytes were isolated
from 23-month-old Sprague-Dawley rats (Harlan Labora-
tories, Indianapolis, Indiana).
Echocardiography. Echocardiography was performed un-
der light anesthesia as previously reported (23). Data were
acquired and analyzed without knowledge of group identity.
LV in vivo physiologic studies. A 1.4-F conductance-
micromanometer catheter was used to measure LV pressure
and volume to assess the LV end-systolic pressure-volume
relationship (ESPVR) as previously reported (18). Data
were acquired and analyzed without knowledge of group
identity.
Necropsy and LV fibrosis assessment. Body and LV
weights (including septum) and tibial lengths were re-
corded. A short-axis midwall LV ring was formalin fixed
and paraffin embedded. The LV sections were stained with
picrosirius red, and collagen fractional area was quantified
using NIH ImageJ software (24).
Biochemistry studies. Total RNA extraction and quanti-
tative reverse transcriptase-polymerase chain reaction were
performed as previously reported (24). LV samples were
homogenized and used for Western blotting as described
previously (23). AC activity, cAMP-dependent protein
kinase (PKA) activity, and caspase 3/7 activity in LV
samples were measured as reported (18).
Calcium uptake. LV tissues were homogenized, and the
ATP-dependent initial rate of SR calcium uptake was
measured by a modified Millipore filtration technique as
reported (20). eCalcium transients. Cardiac myo-
cytes were isolated from adult
rats as previously described (25),
plated on laminin-coated 25-mm
glass coverslips, and infected
with adenovirus encoding green
fluorescent protein or murine AC6
(400 viral particles/cell). Forty
hours after infection, cells were
loaded with the calcium-sensitive
fluorescent indicator Fura-2 AM
(3 M), and the intracellular cal-
ium concentration was moni-
ored using a digital fluorescence
maging system (Intracellular
maging, Cincinnati, Ohio), as
escribed previously (23). To as-
ess SR calcium load, caffeine-
nduced calcium release was ini-
iated by addition of 10 mM
affeine to Tyrode’s solution.
he peak amplitude of calcium
ransients was calculated from
he baseline and the transient rise
fter caffeine treatment. Data
ere acquired and analyzed without knowledge of group
dentity.
tatistical analysis. Results are shown as mean  SE.
roup differences were compared using unpaired, 2-tailed
tudent t test. The null hypothesis was rejected when p 0.05.
esults
C activity in aging hearts. To confirm that aging is
ssociated with decreased AC activity in the heart
5,14,16,26), we measured LV cAMP production in 7- and
0-month-old mice. There were a 43% reduction in basal
p  0.0001), a 56% reduction in isoproterenol-
timulated (p  0.04), and a 58% reduction in NKH477-
timulated LV cAMP production (p  0.0001) in 20-
ersus 7-month-old mice (Fig. 1A). We also found a 59%
eduction of mRNA expression of AC6, a major cardiac
C isoform, in LV samples from 20- versus 7-month-old
ouse hearts (Fig. 1B).
chocardiography. Aging was associated with a decline in
V ejection fraction (7-month-old [n  13]: 80  3%;
0-month-old [n  17]: 57  10%; p  0.0001). Both 7-
nd 20-month-old mice with cardiac-directed and regulated
C6 expression were randomized, and AC6 expression was
ctivated in the AC6-On but not the AC6-Off group.
here were no group differences (AC6-On vs. AC6-Off
roup) in any of the echocardiographic measures before
ctivation of AC6 expression. However, in 20-month-old
ice, activation of AC6 expression increased LV ejection
raction (Table 1). These mice also showed reduced LV
Abbreviations
and Acronyms
AC  adenylyl cyclase
AR  -adrenergic
receptor
CHF  congestive heart
failure
cTnI  cardiac troponin I
ESPVR  end-systolic
pressure-volume
relationship
LV  left ventricular
LV/TL  LV weight to
tibial length ratio
MMP  matrix
metalloproteinase
PKA  cAMP-dependent
protein kinase
PLN  phospholamban
SERCA2a  sarcoplasmic
reticulum calcium-
ATPase2a
SR  sarcoplasmic
reticulumnd-systolic dimension after AC6 expression was activated
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AC6 Function in Aged Hearts May 3, 2011:1846–55(p  0.05), consistent with improved LV ejection fraction.
Other measures showed no group differences. In 7-month-
old mice, activation of cardiac AC6 expression did not
change LV ejection fraction or any of the other echocardio-
graphic measures (Table 1).
LV contractile function. Activation of cardiac-directed
AC6 expression increased the slope of ESPVR by 2.6-fold
in 20-month-old mice (AC6-Off [n  10]: 1.8  0.6 mm
Hg/l; AC6-On [n  9]: 4.6  1.0 mm Hg/l; p  0.04)
Figs. 2A and 2B). AC6 expression in 20-month-old mice
as also associated with an increased rate of LV pressure
evelopment (LV  dP/dt) (p  0.002) (Fig. 2C) and
ncreased stroke work (p  0.04) (Fig. 2D). There were no
group differences in stroke volume (AC6-Off [n  10]: 19
 2 l; AC6-On [n  10]: 20  3 l; p  0.78) and
ardiac output (AC6-Off [n 10]: 7 1 ml/min; AC6-On
n 10]: 10 2 ml/min; p 0.20) in 20-month-old mice.
eart rate was similar in both groups (AC6-Off [n  10]:
44  31 beats/min; AC6-On [n  10]: 469  27
eats/min; p  0.55). However, in 7-month-old mice,
ctivation of AC6 expression did not affect the slope of
SPVR (AC6-Off [n 7]: 4.3 0.4 mm Hg/l; AC6-On
n 6 ]: 4.0  0.6 mm Hg/l; p  0.69) and dP/dt
Figure 1 Aging Associated With Reduced LV AC Activity and A
(A) Basal and isoproterenol- (GTPs) and NKH477 (NKH)-stimulated cAMP pr
7-month-old mice. (B) Quantitative real-time reverse transcriptase polymerase
20-month-old versus 7-month-old mice. Probability values (values above bars)
bars indicate group size.
Echocardiography MeasurementsTable 1 Echocardiography Measurements
7-Month-Old Mice
AC6-Off (n  7) AC6-On (n  6)
HR, beats/min 597 16 607 14
EDD, mm 3.9 0.5 3.6 0.6
ESD, mm 2.3 0.4 2.0 0.3
EF, % 80 2 81 5
PWTh, mm 0.6 0.02 0.6 0.03
IVSTh, mm 0.6 0.01 0.6 0.02
Transgenic mice at ages 7 and 20 months were randomized into 2 gr
group (AC6-On) but not the other (AC6-Off) for 1 month. Values represe
t tests. *p  0.002 versus same group at 7 months. †Not significantly
7 months.EDD  end-diastolic diameter; EF  ejection fraction; ESD  end-systoli
thickness; NS  not significant; PWTh  posterior wall thickness.AC6-Off [n  7]: 5,448  453 mm Hg/s; AC6-On [n 
]: 7,285  1,073 mm Hg/s; p  0.12).
V relaxation. Activation of cardiac-directed AC6 expres-
ion in 20-month-old mice decreased LV dP/dt (p 
.03) (Fig. 2E). In contrast, AC6 expression in 7-month-
ld mice did not affect LVdP/dt (AC6-Off [n 7]:5,260
425 mm Hg/s; AC6-On [n  6]: 6,827  833 mm
Hg/s; p  0.11).
LV hypertrophy. Activation of cardiac-directed AC6 ex-
pression in 20-month-old mice did not change LV weight
to tibial length ratio (LV/TL) (AC6-Off [n  10]: 7.2 
0.6 mg/mm; AC6-On [n  9]: 7.5  0.5 mg/mm; p 
0.71) or cross-sectional cardiac myocyte area in LV sections
(AC6-Off [n  6]: 649  35 m2; AC6-On [n  6]: 663
21 m2; p 0.74). AC6-Off and AC6-On mice showed
imilar mRNA expression of fetal genes, atrial natriuretic
actor (AC6-Off [n 6]: 100 22%; AC6-On [n 9]: 86
15%; p  0.61), -skeletal muscle actin (AC6-Off [n 
6]: 100  20%; AC6-On [n  9]: 126  24%; p  0.45),
and -myosin heavy chain (AC6-Off [n  6]: 100  19%;
AC6-On [n  9]: 84  32%; p  0.71). In addition,
expression of FHL1, a regulator of LV hypertrophy, showed
no group difference (AC6-Off [n 6]: 100 9%; AC6-On
xpression
on were reduced in left ventricular (LV) samples from 20-month-old versus
reaction showed reduced LV expression of adenylyl cyclase 6 (AC6) mRNA in
m the Student t test (unpaired, 2-tailed). Error bars denote 1 SE; numbers in
20-Month-Old Mice
lue AC6-Off (n  8) AC6-On (n  9) p Value
S 490 20* 515 16* NS
S 4.0 0.2† 3.8 0.1† NS
S 2.8 0.1† 2.3 0.2† 0.05
S 59 3‡ 70 4† 0.02
S 0.9 0.03‡ 0.9 0.02‡ NS
S 0.9 0.04‡ 0.9 0.02‡ NS
spectively. Adenylyl cyclase 6 (AC6) expression was activated in one
n SE. Probability values shown are from unpaired, 2-tailed Student
nt versus same group at 7 months. ‡p  0.001 versus same group atC6 E
oducti
chain
are frop Va
N
N
N
N
N
N
oups, re
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May 3, 2011:1846–55 AC6 Function in Aged Hearts[n  9]: 113  12%; p  0.47). Similarly, activation of
ardiac AC6 expression in 7-month-old mice did not
hange LV/TL (AC6-Off [n  7]: 6.4  0.4 mg/mm;
C6-On [n  6]: 6.2  0.3 mg/mm; p  0.71) or mRNA
xpression of fetal genes and FHL1. Although activation of
C6 expression in 7-month-old mice did not change
ross-sectional cardiac myocyte area in LV sections (AC6-
ff [n  6]: 489  21 m2; AC6-On [n  6]: 465  27
m2; p  0.50), aging was associated with an increase
(7-month-old [n 6]: 489 21m2; 20-month-old [n 6]:
49  35 m2; p  0.003).
Calcium uptake. We compared ATP-dependent initial SR
calcium uptake in LV homogenates from 20-month-old
AC6-Off and AC6-On mice. Activation of AC6 increased
the velocity of calcium uptake in the presence of 0.2 M
nd 2 M calcium (Fig. 3A), the approximate intracellular
calcium concentration range in cardiac myocytes (27). AC6
expression also increased sarcoplasmic reticulum calcium-
ATPase (SERCA2a) affinity for calcium (Fig. 3B). In-
creased calcium uptake and SERCA2a affinity for cal-
cium would be expected to increase cardiac contractile
Figure 2 Cardiac-Directed AC6 Expression Increased LV Functi
(A) LV pressure-volume loops, generated by inferior vena caval occlusion, are sho
volume relationship (ESPVR) in AC6-On mice compared with AC6-Off mice. (C) AC6
expression increased stroke work in hearts from 20-month-old mice. (E) There wa
are from the Student t test (unpaired, 2-tailed). Error bars denote 1 SE; numbersfunction as we observed. In contrast, activation of AC6expression in 7-month-old mice did not change the
velocity of calcium uptake (Fig. 3C) and SERCA2a
affinity for calcium (Fig. 3D).
In addition, we isolated cardiac myocytes from 23-
month-old rats, infected these cells with adenovirus
encoding AC6, and measured the intracellular calcium
concentration under basal and caffeine-stimulated condi-
tions (Fig. 4A). There was no group difference in basal
intracellular calcium concentration in cardiac myocytes
(Fig. 4B). However, there was a 1.5-fold increase in the
peak amplitude of caffeine-stimulated calcium transients
associated with AC6 expression in cardiac myocytes from
aging rats (Fig. 4C). These results indicated that AC6
expression increased calcium storage in aging cardiac
myocytes.
AC6 expression and cAMP production. In 20-month-old
mice, cardiac-directed AC6 transgene expression was asso-
ciated with a 10-fold increase in LV AC6 protein content
(Figs. 5A and 5B). LV expression of other cardiac AC
isoforms (AC2, AC3, AC4, AC5, AC7, and AC9) was
unchanged in these mice (Fig. 5C). Increased AC6 protein
20-Month-Old Mice
) Activation of AC6 expression increased the slope of the end-systolic pressure-
ice showed increased dP/dt compared with AC6-Off mice. (D) Activation of AC6
bstantial increase in dP/dt in AC6-On mouse hearts. Probability values shown
indicate group size. Abbreviations as in Figure 1.on in
wn. (B
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in barscontent was associated with a 1.7-fold increase in
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AC6 Function in Aged Hearts May 3, 2011:1846–55isoproterenol-stimulated cAMP production (p  0.01) and
3-fold increase in forskolin-stimulated cAMP production
p  0.002) in LV samples from 20-month-old mice, and
asal LV cAMP production was not changed (Fig. 5D).
espite unchanged protein expression of PKA catalytic
ubunit (Fig. 5E), PKA activity was increased after activa-
ion of AC6 expression (Fig. 5F), indicating a role of
C6-increased cAMP production in regulating PKA activ-
ty in the aging heart.
rotein phosphorylation. We compared PKA-induced
hosphorylation of cardiac troponin I (cTnI) and phospho-
amban (PLN) in LV homogenates from 20-month-old
C6-Off and AC6-On mice. Activation of cardiac AC6
xpression in these mice was associated with a 1.9-fold
ncrease in phosphorylation of cTnI at the Ser23/24 sites
p 0.01) (Figs. 6A and 6B). No change was found in total
TnI protein content. There was also a 1.9-fold increase in
hosphorylation of PLN at the Ser16 site in LV samples
rom 20-month-old AC6-On mice compared with that of
C6-Off mice (p  0.04; Figs. 6A and 6C), although total
LN protein content was unaltered. Western blotting
howed no group differences in protein content of protein
hosphatase 1 (AC6-Off [n  6]: 1,152  195 densito-
etric units (du); AC6-On [n  9]: 1,153  277 du; p 
1.00) or protein phosphatase 2A (AC6-Off [n  6]: 743 
Figure 3 Activation of Cardiac AC6 Expression Increased Calci
(A) Cardiac-directed AC6 expression improved sarcoplasmic reticulum (SR) calcium
mice (n  6 for each group). (B) Cardiac-directed AC6 expression increased SR ca
(C) AC6 expression did not affect SR calcium uptake in the presence of 0.2 M (
for each group). (D) AC6 expression did not affect SERCA2a affinity for calcium in
t test (unpaired, 2-tailed). Error bars denote 1 SE; numbers in bars indicate group04 du; AC6-On [n  9]: 604  65 du; p  0.25), 2indicating a selective role of AC6-increased PKA activity
in regulating phosphorylation of cTnI and PLN. In
addition, we found no group differences in expression of
SR calcium pump SERCA2a (Fig. 6D), the calcium-
binding protein calsequestrin (Fig. 6E), or Na-Ca2
exchanger 1 (Fig. 6F).
Extracellular matrix. Extracellular matrix remodeling, a
process that involves changes of collagen synthesis, degra-
dation, and cross-linking, leads to increased number and
size of collagen fibers within interstitial spaces. There was
substantial collagen deposition in LV sections from 20-
month-old mice compared with those from 7-month-old
mice (collagen fractional area: 7-month-old [n  7]: 3.1 
1.1%; 20-month-old [n  6]: 15.4  2.5%; p  0.001);
owever, activation of cardiac AC6 expression did not
hange collagen fractional area in 20-month-old mouse
earts (AC6-Off [n  6]: 15.4  2.5%; AC6-On [n  9]:
14.4  2.0%; p  0.77).
We compared mRNA content of type I and III collagens,
2 major constituents of the cardiac extracellular matrix, in
LV samples from 20-month-old AC6-Off and AC6-On
mice. Activation of AC6 expression did not change mRNA
expression of collagen I1 (AC6-Off [n  6]: 100  14%;
AC6-On [n  9]: 129  19%; p  0.30) or III1
(AC6-Off [n  6]: 100  29%; AC6-On [n  9]: 85 
ptake in 20-Month-Old But Not 7-Month-Old Mice
ke in the presence of 0.2 and 2 M calcium in LV samples from 20-month-old
-ATPase2a (SERCA2a) affinity for calcium in LV samples from 20-month-old mice.
33) and 2 M calcium (p  1.00) in LV samples from 7-month-old mice (n  6
mples from 7-month-old mice (p  0.72). Probability values are from the Student
Abbreviations as in Figure 1.um U
upta
lcium
p  0.
LV sa
size.9%; p  0.73). Quantitative reverse transcriptase-
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May 3, 2011:1846–55 AC6 Function in Aged Heartspolymerase chain reaction also showed that AC6 expression
did not change the mRNA content of matrix metallopro-
teinase 2 (MMP2) (AC6-Off [n  6]: 100  14%;
C6-On [n  9]: 135  20%; p  0.22) or MMP8
AC6-Off [n  6]: 100  16%; AC6-On [n  9]: 87 
4%; p  0.55). Similar levels of periostin mRNA, a
egulator of cardiac fibrosis, were seen in LV samples from
0-month-old AC6-Off and AC6-On mice (AC6-Off
n 6]: 100 16%; AC6-On [n 9]: 121 19%; p 0.44).
here were no group differences in mRNA expression of
lastin (AC6-Off [n  6]: 100  10%; AC6-On [n  9]:
21  18%; p  0.69) or fibronectin (AC6-Off [n  6]:
00  17%; AC6-On [n  9]: 89  19%; p  0.39).
ardiac myocyte apoptosis. Terminal deoxynucleotidyl
ransferase-mediated dUTP nick-end labeling was used
o evaluate apoptosis. In 20-month-old mouse hearts,
C6 expression did not change the apoptosis rate (data
ot shown). AC6-Off and AC6-On mice showed com-
arable LV mRNA expression of Bcl2 (AC6-Off [n  6]:
00  27%; AC6-On [n  9]: 104  18%; p  0.89), an
mportant apoptosis inhibitor. Increased AC6 expression in
0-month-old mouse hearts did not change LV caspase 3/7
ctivity (AC6-Off [n  6]: 40.3  2.4 U/mg; AC6-On
n  9]: 37.6  2.0 U/mg; p  0.41). Finally, no group
ifference in expression of superoxidase dismutase 2 was
een after activation of AC6 expression in 20-month-old
ice (AC6-Off [n  6]: 100  6%; AC6-On [n  9]: 93
Figure 4 Increased Calcium Storage in Cardiac Myocytes From
(A) Representative calcium transients recorded from cardiac myocytes stimulated
protein (CON) (left panel); cardiac myocyte infected with adenovirus encoding AC6
cium concentration in cardiac myocytes. Data were derived from 67 CON cells and
of caffeine-stimulated calcium transients recorded from cardiac myocytes. Data we
from the Student t test (unpaired, 2-tailed). Error bars denote 1 SE. Abbreviations6%; p  0.46).iscussion
he most important finding of this study is that activation of
ardiac AC6 expression improved aging-impaired LV con-
ractile function and relaxation. These beneficial effects
ere associated with increases in cAMP production, PKA
ctivity, and phosphorylation of PLN and cTnI. Moreover,
oth SR calcium uptake and SR calcium storage in cardiac
yocytes were increased following activation of AC6 expres-
ion. Improved SR calcium uptake appears to be the mecha-
ism by which AC6 expression evokes these beneficial effects.
Results from our previous studies (17,18,28,29) indicate
hat increased cardiac AC6 has beneficial effects in the
ailing heart. However, increased expression of other ele-
ents of the AR signaling pathway (e.g., 1AR, Gs,
PKA) is associated with pronounced deleterious effects on
the heart, including precipitation of heart failure, fibrosis,
and increased mortality (30–33). These results indicate that
AC6 is unique among AR signaling elements in regulating
cardiac function. In clinical settings, increased age is asso-
ciated with reduced LV function (1–4), and elderly patients
have an increased prevalence of heart failure (7–9). In this
study, we tested the hypothesis that activation of AC6
expression increases function of the aging heart. We as-
sessed LV contractile function by 3 different methods: LV
ejection fraction, dP/dt, and slope of ESPVR (34). Each
of these measures led to the same conclusion that increased
expression of cardiac AC6 improves LV contractile function
onth-Old Rats Following AC6 Gene Transfer
affeine. Cardiac myocyte infected with adenovirus encoding green fluorescent
panel). (B) The bar graph shows no group difference in basal intracellular cal-
6 cells (blinded; p  0.40). (C) AC6 expression increased the peak amplitude
ived from 41 CON cells and 51 AC6 cells (blinded). Probability values shown are
Figure 1.23-M
with c
(right
77 AC
re der
as inin the aging heart.
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AC6 Function in Aged Hearts May 3, 2011:1846–55Calcium plays a crucial role in controlling LV contraction
and relaxation. During every heartbeat, calcium is taken up
and then released from the SR. Aged hearts show dysfunc-
tional SR calcium uptake (35,36), which reflects reduced SR
calcium pump SERCA2a content (37,38) and reduced PLN
phosphorylation (37–39). In the current study, we found
that activation of AC6 expression increased PLN phosphor-
ylation at the Ser16 site in 20-month-old mice, whereas it
did not change SERCA2a protein expression (Fig. 6). This
change of PLN phosphorylation was associated with in-
creased cAMP-generating capacity and PKA activity. Most
importantly, activation of cardiac AC6 expression increased
SR calcium uptake and SERCA2a affinity for calcium in
these 20-month-old mice (Figs. 3A and 3B). These results
indicate that AC6 expression improves calcium uptake by
activating a signaling cascade leading to increased PLN
phosphorylation in 20-month-old mice. Improvement of
calcium uptake may be of mechanistic importance for the
observed increased LV function after AC6 expression (Fig. 2),
Figure 5 Cardiac-Directed AC6 Expression Activated cAMP Sig
(A) Representative Western blot shows marked increase in AC6 protein content in
ples from AC6-Off and AC6-On mice. (C) AC6 expression did not affect expression
LV cAMP generation capacity. (E) No group difference was observed in protein con
mice showed increased PKA activity. Probability values are from the Student t t
du  densitometric unit; GAPDH  glyceraldehyde-3-phosphate dehydrogenase; otgiven the fact that deletion of AC6 decreased calciumuptake and impaired LV function (23). This notion is
further supported by our findings that activation of AC6
expression did not improve SR calcium uptake and
SERCA2a affinity for calcium in 7-month-old mouse hearts
(Figs. 3C and 3D), where LV contractile function was
unaffected.
Cardiac myocytes isolated from the hearts of 20-month-
old mice may not be suitable for accurate studies for calcium
transient measurements. For example, despite our substan-
tial experience in isolated cardiac myocytes from mice, we
found a 25% cell death rate and spontaneous beating in
one-third of the viable cells. Because of these unavoidable
problems, we elected to use instead cardiac myocytes iso-
lated from elderly rats for calcium transient measurements.
We used rats at the age of 23 months, rather than 20
months, to compensate in part for life span difference
between mice and rats. Our data from caffeine-stimulated
SR calcium transient measurements provided direct evi-
dence that AC6 expression increased SR storage. But more
g in 20-Month-Old Mouse Hearts
mples from AC6-On mice. (B) The bar graph summarizes AC6 content in LV sam-
er AC isoforms in the heart. (D) AC6 expression was associated with increased
f cAMP-dependent protein kinase (PKA) catalytic subunit (p  0.30). (F) AC6-On
paired, 2-tailed). Error bars denote 1 SE; numbers in bars indicate group size.
breviations as in Figure 1.nalin
LV sa
of oth
tent o
est (un
her abimportantly, we showed that AC6 expression increased SR
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May 3, 2011:1846–55 AC6 Function in Aged Heartscalcium uptake using LV samples directly from our 20-
month-old mice.
Cardiac troponin I is a sarcomeric protein directly regu-
lating the LV function in concert with intracellular calcium
signals. In addition to decreased PLN phosphorylation (at
the Ser16 site), decreased cTnI phosphorylation (at the
Ser23/24 sites) is also a seminal alteration underlying
impaired LV function of failing human hearts (40,41). The
relative contributions of phosphorylation of cTnI versus
PLN are not clear (42). Nevertheless, cTnI phosphorylation
increases maximal tension development, cross-bridge kinet-
ics, and systolic power production (42,43). Expression of
pseudophosphorylated cTnI at the Ser23/24 sites increased
Figure 6 Cardiac-Directed AC6 Expression Increased Phosphor
(A) Representative Western blots show marked increase in protein content of
(Ser16) in AC6-On mouse hearts. (B) The bar graph summarizes protein content o
of phospho-PLN from Western blotting. (D) No group difference was observed in p
content of calsequestrin (p  0.37). (F) AC6 expression did not change mRNA ex
Student t test. Error bars denote 1 SE; numbers in bars indicate group size. AbbreLV contractility in mice (44). Moreover, improved LVfunction by cardiac AC6 expression is linked to increased
cTnI phosphorylation at the Ser23/24 sites in failing hearts
(18). Importantly, cardiac aging is associated with decreased
cTnI phosphorylation (45), suggesting that cTnI phosphor-
ylation is also a contributing factor for reduced LV function in
aging hearts. In the present study, we showed that increased
LV function was correlated with increased cTnI phosphoryla-
tion after activation of AC6 expression in aging hearts (Fig. 6).
These results suggest that AC6 expression, in addition to its
effects on SR calcium uptake, directly regulates the property of
thin filament in the contractile apparatus.
The extracellular matrix, composed mainly of fibrillar
collagens (46), provides an architectural scaffold for cardiac
n of cTnI and PLN in 20-Month-Old Mouse Hearts
ho–cardiac troponin I (cTnI) (Ser23/24) and phospho-phospholamban (PLN)
pho-cTnI from Western blotting. (C) The bar graph summarizes protein content
content of SERCA2a (p  0.61). (E) No group difference was seen in protein
n of Na-Ca2 exchanger 1 (p  0.27). Probability values shown are from the
ns as in Figures 1, 3, and 5.ylatio
phosp
f phos
rotein
pressio
viatiocells and contributes to the maintenance of LV function
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AC6 Function in Aged Hearts May 3, 2011:1846–55(47,48). In this study, we confirmed that cardiac aging is
associated with increased collagen deposition. However,
activation of AC6 expression in 20-month-old mice did not
change LV collagen deposition, indicating that the im-
proved LV function does not likely reflect a change in LV
collagen content. Additional support for this notion is our
finding that AC6 expression did not change expression of
type I and III collagens, the major cardiac collagen isoforms
contributing 75% to 80% (type I) and 15% to 20% (type III)
of total collagen content (49). Expression of MMPs and
periostin was not changed by activation of AC6 expression,
although aging is associated with increased expression of
these important extracellular matrix proteins (50,51). In
addition, our data showed that increased cardiac AC6
expression in 20-month-old mice was not associated with
changes in apoptosis or reactive oxygen species. Taken
together, our results suggest that activation of AC6 expres-
sion improves LV function through increased SR calcium
uptake.
Whether LV hypertrophy in aged mice affected our
results is an important consideration. Although posterolat-
eral and septal wall thicknesses at the mid-papillary muscle
level were increased (0.3 mm) in aged mice (Table 1), the
echocardiographic estimate of LV mass, which considers
more than a single plane, showed no difference between
mice age 20 months versus 7 months (data not shown).
Cardiac myocyte cross-sectional area was increased, but the
13% increase in LV/TL did not reach statistical signifi-
cance. The disparity between cross-sectional area and LV
mass at necropsy vis-à-vis LV hypertrophy in 7- versus
20-month-old mice may reflect LV hypertrophy associated
with concomitant aging-related increases in cardiac myocyte
apoptosis (52) or the limitations of assessing cardiac myo-
cyte cross-sectional area in hearts not obtained after dia-
stolic arrest. Similarly, others have documented that, in aged
rats, despite increased myocyte cross-sectional area (52), LV
mass and LV/TL were not increased (53). Our study
showed that activation of cardiac AC6 expression, which
had no independent effect on LV hypertrophy, improved
aging-impaired LV contractile function and relaxation.
Improved SR calcium uptake appears to be of mechanistic
importance for these beneficial effects.
Gene manipulation has recently been promoted to probe
disease mechanism and test treatments designed to attenu-
ate the progression of aging-related diseases. Transgenic
lines with increased or decreased expression of a candidate
gene typically are used, and if deterioration of heart function
is prevented, the candidate gene (or deletion of this gene) is
said to have “rescued” the heart. However, a superior
strategy, and one used in the present study, is to activate
gene expression only when the adverse effect of aging is
present. We accomplished this by activating AC6 expres-
sion in the setting of declining heart function in aged mice.
Although additional studies will be required to determine
whether activation of cardiac AC6 expression reduces mor-tality, our current data suggest a therapeutic potential for
increased AC6 expression in aging hearts.
Conclusions
Activation of cardiac-directed AC6 expression improves LV
function in aged hearts. This is associated with increased
cAMP production and PKA activity and phosphorylation of
PLN and cTnI. Improved SR calcium uptake in cardiac
myocytes appears to be of mechanistic importance for these
beneficial effects.
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